Online Hatha Yoga Program as an Add-On Therapy for Episodic High-Frequency Migraine

Sponsor
University of Seville
Study ID
NCT07694063
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 65 Years
Healthy Volunteers
Not accepted

Interventions

  • Control group (receiving standard medical therapy alone) — OTHER
    * Continuation of usual pharmacological migraine treatment * No structured exercise/yoga program * Usual clinical follow-up * Post-study access to yoga program offered
  • Hatha yoga — OTHER
    * Online Hatha Yoga Program (12 weeks + 2-week follow-up) * 2 sessions per week * 30-45 minutes per session * Asynchronous video-based home practice * Standard pharmacological treatment maintained

Study Details

This randomized controlled trial aims to evaluate the effectiveness and feasibility of an online Hatha yoga program as an adjunct (add-on) therapy for patients with high-frequency episodic migraine. Participants will be randomly assigned to either an intervention group receiving a 12-week home-based online Hatha yoga program in addition to usual pharmacological treatment, or a control group receiving usual pharmacological care only. Outcomes include migraine frequency, pain intensity, functional disability, sleep quality, psychological symptoms, and adherence.

Key Dates

First listed
Jul 9, 2026
Start date
Jan 27, 2026
Status verified
Jun 2026
Primary completion
Oct 30, 2026
Completion
Oct 30, 2026

Study Design

Enrollment
60 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Arm 1: Experimental Group Label: Hatha Yoga + Usual Pharmacological Treatment Type: Experimental
    * Online Hatha Yoga Program (12 weeks + 2-week follow-up) * 2 sessions per week * 30-45 minutes per session * Asynchronous video-based home practice * Standard pharmacological treatment maintained
  • Active Comparator: Arm 2: Control Group Label: Usual Pharmacological Treatment Only Type: Active Comparator / Control
    * Continuation of usual pharmacological migraine treatment * No structured exercise/yoga program * Usual clinical follow-up * Post-study access to yoga program offered

Primary Outcome Measure

Migraine Frequency [ Time Frame: Baseline and Week 14 ]

Central Contacts

Find similar trials

Nationwide
Migraine trialsNeurology trials

Related Studies